Targeted metabolomics in neurodegenerative diseases

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Unblock content Accept required service and unblock content

---

Neurodegenerative diseases and the microbiome

In this webinar, biocrates senior scientist Barbara Ustaszewski shares information about

• Why Alzheimer’s and other neurodegenerative disease can only be understood by looking at the metabolic perspective
• How different disease stages can be characterized by their metabolic signature
• How absolute quantification of biological metabolites empowers the discovery of deeper pathophysiological insights with direct clinical relevance

---

Related articles

• Population based medicine – Transform medicine with metabolomics – part 4 of 5
• Spermidine : Unlocking the secrets of cellular aging and longevity
• Precision medicine – Transform medicine with metabolomics – part 3 of 5
• Propionic acid – A short-chain fatty acid with big impact
• Predictive medicine – Transform medicine with metabolomics – part 2 of 5